| Literature DB >> 25714205 |
Patrick Bastos Metzger1, Fabio Henrique Rossi1, Samuel Martins Moreira2, Mario Issa3, Nilo Mitsuru Izukawa4, Jarbas J Dinkhuysen1, Domingos Spina Neto5, Antônio Massamitsu Kambara6.
Abstract
INTRODUCTION: The management of thoracic aortic disease involving the ascending aorta, aortic arch and descending thoracic aorta are technically challenging and is an area in constant development and innovation.Entities:
Mesh:
Year: 2014 PMID: 25714205 PMCID: PMC4408814 DOI: 10.5935/1678-9741.20140056
Source DB: PubMed Journal: Rev Bras Cir Cardiovasc
Fig. 1Angiotomography with multiplanar and three-dimensional reconstruction
A: Axial section demonstrating the dissection of the left subclavian artery origin. B: Larger diameter of the aorta. C: Sagittal section. D: Superior mesenteric artery originating from the true light. E: Involvement of the abdominal aorta. F: Dissection at the level of the left iliac artery. G: Three-dimensional reconstruction of the left anterior oblique. H: Threedimensional reconstruction of the right anterior oblique
Fig. 2Anchoring zones of the thoracic aneurysm according to Ishimaru and Mitchell classification
Fig. 3Carotid-left subclavian graft with prosthesis anchoring in Zone 2. A=Angiotomography in axial section showing massive thoracic aneurysm without proximal landing zone. B=Three-dimensional reconstruction of pre-implanted stents. C=Digital subtraction angiotomography with endoprosthesis anchoring in Zone 2 and carotid-suclavian patent graft. D=Three-dimensional angiographic reconstruction after stent implantation without leaks
Clinical data (n=18)
| Value (%) | |
|---|---|
| Characteristics population | n=18 |
| Mean age (years) | 62.3±8.3 |
| Male | 12 (66.7%) |
| Symptomatic disease | 5 (27.8%) |
| True TAA | 6 (33.3%) |
| Pseudoaneurysms | 1 (5.5%) |
| AAA | 4 (22.2%) |
| Acute type B dissection | 2 (11.1%) |
| Acute type A dissection | 3 (16.6%) |
| Chronic type A dissection | 2 (11.1%) |
| Diabetes Mellitus | 6 (33.3%) |
| Hypertension | 18 (100%) |
| Dyslipidemia | 12 (66.7%) |
| Smoking | 12 (66.7%) |
| Chronic renal failure | 1 ( 5.5%) |
| Ischaemic heart disease | 5 (27.8%) |
| Chronic Obstructive Pulmonary Disease | 8 (44.4%) |
| Prior aortic surgery | 3 (16.7%) |
| Cerebrovascular accident | 0 |
| Congestive heart failure | 4 (22.2%) |
TAA= thoracic aortic aneurysm; AAA= aortic arch aneurysm; Stanford type A and B classification
Technical details of 18 supra-aortic trunk revascularizations.
| Technical details | Number of events (%) | Revascularization description |
|---|---|---|
| Staged procedures | 13 (72.2%) | |
| Zone 0 | 8 (44.4%) | 2 Ao-Ao bridges + BCT revascularization + LCC + Sbc |
| 5 Ao-BCT bridges + Ao-LCC + Sbc | ||
| 1 Ao-BCT bridge (single carotid aortic trunk) + BCT proximal embolization | ||
| Zone 1 | 4 (22.2%) | 3 RCC-LCC bridges + Sbc transposition |
| 1 Sbc-LCC transposition (single carotid trunk) | ||
| Zone 2 | 6 (33.3%) | 3 Sbc-LCC transposition |
| 3 Sbc-LCC bridges | ||
| Numbers of endoprostheses used | 21 | 15 patients used endoprosthesis |
| 3 patients used two endoprostheses |
Ao-Ao=aorto-aortic; BCT=brachiocephalic trunk; LCC=left common carotid artery; Sbc=subclavian artery; RCC=Right commom carotid artery
Fig 4Carotid-carotid graft associated with transposition of the left subclavian artery and stent-graft implantation in Zone 1. A: Angiotomography in sagittal section with thoracic aneurysm without proper anchoring zone in Zone 2 due to extreme proximity between the left carotid and the left subclavian arteries. B: Angiotomography in axial section showing massive thoracic aneurysm. C: Angiotomography with volume reconstruction. D: Supra-aortic trunk revascularizatoins with carotid-carotid graft associated with transposition of the left subclavian artery. E: Aortography before stent implantation with patency of anatomical extra grafts. F: Aortography after stent implantation demonstrating the aortic stent in Zone 1, no leaks and patency of supra-aortic trunks
Fig. 5Brachiocephalic ascending aorta graft associated with carotid-carotid graft placement of vascular plug and aortic endoprosthesis implantation in Zone 0. Intentional occlusion of left subclavian artery
Intra-and perioperative complications (n = 18).
| Number of events (%) | |
|---|---|
| Outcomes | Sample n=18 |
| Intraoperative complications | |
| Peripheral embolization | 0 |
| Femoral lesion | 0 |
| Cardiac tamponade | 1 (5.5%) |
| Intra-hospital complications | |
| Paraplegia | 1 (5.5%) |
| Pulmonary complications | 2 (11.1%) |
| ICVA | 1 (5.5%) |
| Acute renal failure | 1 (5.5%) |
| Acute myocardial infarction | 1 (5.5%) |
| Death | 2 (11.1%) |
ICVA=Ischemic cerebrovascular accident
Primary leak data (n = 18).
| Number of events (%) | |
|---|---|
| Endoleak types | Sample n=18 |
| Total | 3 (16.6%) |
| Type IA | 2 (11.1%) |
| Type IB | 0 |
| Type II | 1 (5.5%) |
| Type III | 0 |
| Type IV | 0 |
| Reintervention rate | 3 (16.6%) |
| Authors' roles & responsibilities | |
|---|---|
| PBM | Analysis and/or interpretation of data, statistical analysis, final approval of the manuscript, conception and design of the study, operations and/or experiments, manuscript writing or critical review of its contents |
| FHR | Final approval of the manuscript, operations and/or experiments, manuscript writing or critical review of its contents |
| SMM | Final approval of the manuscript, operations and/or experiments |
| MI | Final approval of the manuscript, operations and/or experiments |
| NMI | Final approval of the manuscript, operations and/or experiments |
| JJD | Final approval of the manuscript, operations and/or experiments |
| DSN | Operations and/or experiments |
| AMK | Final approval of the manuscript, operations and/or experiments, manuscript writing or critical review of its contents |